FPR2 Participates in Epithelial Ovarian Cancer (EOC) Progression Through RhoA-mediated M2 Macrophage Polarization

Overview

Journal J Ovarian Res

Publisher Biomed Central

Specialties Gynecology & Obstetrics
Reproductive Medicine

Date 2021 Dec 21

PMID 34930387

Citations 8

Authors

Xiaohui Xie

Juan He

Qiong Wang

Yaqiong Liu

Weiwei Chen

Kun Shi

Affiliations

Soon will be listed here.

Abstract

Background: In our previous study, we found that formyl peptide receptor 2 (FPR2) promoted the invasion and metastasis of epithelial ovarian cancer (EOC) and could be a prognostic marker for EOC. In this study, we aimed to study the possible mechanism of FPR2 in promoting EOC progression.

Methods: EOC cell lines with ectopic FPR2 expression and knockdown as well as their control cell lines were established, and the expression change of RhoA in each cell line was evaluated by real time quantitative polymerase chain reaction (RT-qPCR) and Western blot. Wound healing and Transwell assays were performed to detect the migratory ability of EOCs affected by FPR2 and RhoA. The supernatant of each EOC cell line was used to coculture with macrophages, and then we tested M1 and M2 macrophage biomarkers in the supernatants by flow cytometry. The THP-1 cell line was also induced to differentiate into M1 and M2 macrophages, and FPR2 and RhoA expression in each macrophage cell line was detected by RT-qPCR and Western blot. A tumour xenograft model was established with SKOV3 and SKOV3 cell lines, and tumour volumes and weights were recorded.

Results: RhoA expression was significantly increased in EOCs along with the overexpression of FPR2, which showed a positive correlation by Pearson correlation analysis. Ectopic FPR2 expression contributes to the migratory ability of EOCs, and a RhoA inhibitor (C3 transferase) impairs EOC migration. Furthermore, FPR2 stimulated the secretion of Th2 cytokines by EOCs, which induced macrophages to differentiate to the M2 phenotype, while a RhoA inhibitor stimulated the secretion of Th1 cytokines and induced macrophages to differentiate to the M1 phenotype. Moreover, compared with M1 macrophages and THP-1 cells, FPR2 and RhoA expression was significantly upregulated in M2 macrophages.

Conclusion: FPR2 stimulated M2 macrophage polarization and promoted invasion and metastasis of ovarian cancer cells through RhoA.

Citing Articles

The role of MUC16 in tumor biology and tumor immunology in ovarian cancer.

Yang N, Zhou X, Gong Y, Deng Z BMC Cancer. 2025; 25(1):294.

PMID: 39972413 PMC: 11837316. DOI: 10.1186/s12885-025-13461-0.

ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer.

An Y, Duan H J Ovarian Res. 2024; 17(1):84.

PMID: 38637813 PMC: 11025218. DOI: 10.1186/s13048-024-01394-4.

From odor to oncology: non-canonical odorant receptors in cancer.

Park S, Greer P, Lee N Oncogene. 2023; 43(5):304-318.

PMID: 38087050 DOI: 10.1038/s41388-023-02908-y.

Damage-mediated macrophage polarization in sterile inflammation.

Koncz G, Jenei V, Toth M, Varadi E, Kardos B, Bacsi A Front Immunol. 2023; 14:1169560.

PMID: 37465676 PMC: 10351389. DOI: 10.3389/fimmu.2023.1169560.

The relationship between microRNAs and bladder cancer: are microRNAs useful to predict bladder cancer in suspicious patients?.

Kaba M, Pirincci N, Demir M, Kaba S, Oztuzcu S, Verep S Int Urol Nephrol. 2023; 55(10):2483-2491.

PMID: 37338656 DOI: 10.1007/s11255-023-03666-2.

References

Yuan X, Zhang J, Li D, Mao Y, Mo F, Du W . Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Gynecol Oncol. 2017; 147(1):181-187. DOI: 10.1016/j.ygyno.2017.07.007. View

Machado M, Tavares L, Souza G, Queiroz-Junior C, Ascencao F, Eustaquio Lopes M . The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia. FASEB J. 2020; 34(2):2749-2764. DOI: 10.1096/fj.201902172R. View

Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

Matulonis U, Sood A, Fallowfield L, Howitt B, Sehouli J, Karlan B . Ovarian cancer. Nat Rev Dis Primers. 2016; 2:16061. PMC: 7290868. DOI: 10.1038/nrdp.2016.61. View

Ip W, Hoshi N, Shouval D, Snapper S, Medzhitov R . Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science. 2017; 356(6337):513-519. PMC: 6260791. DOI: 10.1126/science.aal3535. View

Faour W, Fayyad-Kazan H, El Zein N . fMLP-dependent activation of Akt and ERK1/2 through ROS/Rho A pathways is mediated through restricted activation of the FPRL1 (FPR2) receptor. Inflamm Res. 2018; 67(8):711-722. DOI: 10.1007/s00011-018-1163-6. View

Chen X, Zhuo S, Zhu T, Yao P, Yang M, Mei H . Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization. Diabetes. 2019; 68(6):1130-1142. PMC: 6905484. DOI: 10.2337/db18-0469. View

Liu Y, Chen K, Wang C, Gong W, Yoshimura T, Liu M . Cell surface receptor FPR2 promotes antitumor host defense by limiting M2 polarization of macrophages. Cancer Res. 2012; 73(2):550-60. PMC: 3549056. DOI: 10.1158/0008-5472.CAN-12-2290. View

Bast Jr R, Hennessy B, Mills G . The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009; 9(6):415-28. PMC: 2814299. DOI: 10.1038/nrc2644. View

10.

Haga R, Ridley A . Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases. 2016; 7(4):207-221. PMC: 5129894. DOI: 10.1080/21541248.2016.1232583. View

11.

Hodge R, Ridley A . Regulating Rho GTPases and their regulators. Nat Rev Mol Cell Biol. 2016; 17(8):496-510. DOI: 10.1038/nrm.2016.67. View

12.

Li Y, Ye D . Molecular biology for formyl peptide receptors in human diseases. J Mol Med (Berl). 2013; 91(7):781-9. DOI: 10.1007/s00109-013-1005-5. View

13.

Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y . Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene. 2011; 30(36):3887-99. DOI: 10.1038/onc.2011.112. View

14.

Cleghorn W, Bulus N, Kook S, Gurevich V, Zent R, Gurevich E . Non-visual arrestins regulate the focal adhesion formation via small GTPases RhoA and Rac1 independently of GPCRs. Cell Signal. 2017; 42:259-269. PMC: 5732042. DOI: 10.1016/j.cellsig.2017.11.003. View

15.

Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N . IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol. 2011; 12(3):231-8. DOI: 10.1038/ni.1990. View

16.

Yin M, Li X, Tan S, Zhou H, Ji W, Bellone S . Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016; 126(11):4157-4173. PMC: 5096908. DOI: 10.1172/JCI87252. View

17.

Mills C, Ley K . M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun. 2014; 6(6):716-26. PMC: 4429858. DOI: 10.1159/000364945. View

18.

Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro M . Macrophage polarization in tumour progression. Semin Cancer Biol. 2008; 18(5):349-55. DOI: 10.1016/j.semcancer.2008.03.004. View

19.

Ye R, Boulay F, Wang J, Dahlgren C, Gerard C, Parmentier M . International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev. 2009; 61(2):119-61. PMC: 2745437. DOI: 10.1124/pr.109.001578. View

20.

Lamichhane P, Karyampudi L, Shreeder B, Krempski J, Bahr D, Daum J . IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer. Cancer Res. 2017; 77(23):6667-6678. PMC: 5712245. DOI: 10.1158/0008-5472.CAN-17-0740. View